The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Diabetes Care Devices & Drugs-Global Market Insights and Sales Trends 2025
Synopsis
Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs.
The global Diabetes Care Devices & Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Care Devices & Drugs in various end use industries. The expanding demands from the Hospital and Household, are propelling Diabetes Care Devices & Drugs market. Insulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rapid Acting Insulin segment is estimated at % CAGR for the next seven-year period.
The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Care Devices & Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Care Devices & Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Care Devices & Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Care Devices & Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Care Devices & Drugs covered in this report include Abbott Laboratories, Ascensia Diabetes Care Holdings, AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly And, Hoffmann-La Roche, Johnson & Johnson, Medtronic PLC and Novartis, etc.
The global Diabetes Care Devices & Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Ascensia Diabetes Care Holdings
AstraZeneca
Boehringer Ingelheim GmbH
Eli Lilly And
Hoffmann-La Roche
Johnson & Johnson
Medtronic PLC
Novartis
Novo Nordisk A/S
Ypsomed
Terumo
Global Diabetes Care Devices & Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Care Devices & Drugs market, Segment by Type:
Insulin
Rapid Acting Insulin
Short Acting Insulin
Diabetes Care Devices
Diabetes Monitoring Devices
Other
Global Diabetes Care Devices & Drugs market, by Application
Hospital
Household
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Care Devices & Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Diabetes Care Devices & Drugs is used to treat diabetes equipment and drugs.
The global Diabetes Care Devices & Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Diabetes Care Devices & Drugs in various end use industries. The expanding demands from the Hospital and Household, are propelling Diabetes Care Devices & Drugs market. Insulin, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Rapid Acting Insulin segment is estimated at % CAGR for the next seven-year period.
The global diabetes care devices & drugs market is mainly driven by thereasingidence & prevalence of diabetes, technological advancements, rising obesity rate, andreasingdentary lifestyle & improper diet.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Diabetes Care Devices & Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Diabetes Care Devices & Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Diabetes Care Devices & Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Diabetes Care Devices & Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Diabetes Care Devices & Drugs covered in this report include Abbott Laboratories, Ascensia Diabetes Care Holdings, AstraZeneca, Boehringer Ingelheim GmbH, Eli Lilly And, Hoffmann-La Roche, Johnson & Johnson, Medtronic PLC and Novartis, etc.
The global Diabetes Care Devices & Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Abbott Laboratories
Ascensia Diabetes Care Holdings
AstraZeneca
Boehringer Ingelheim GmbH
Eli Lilly And
Hoffmann-La Roche
Johnson & Johnson
Medtronic PLC
Novartis
Novo Nordisk A/S
Ypsomed
Terumo
Global Diabetes Care Devices & Drugs market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Diabetes Care Devices & Drugs market, Segment by Type:
Insulin
Rapid Acting Insulin
Short Acting Insulin
Diabetes Care Devices
Diabetes Monitoring Devices
Other
Global Diabetes Care Devices & Drugs market, by Application
Hospital
Household
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Diabetes Care Devices & Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Diabetes Care Devices & Drugs
1.1 Diabetes Care Devices & Drugs Market Overview
1.1.1 Diabetes Care Devices & Drugs Product Scope
1.1.2 Diabetes Care Devices & Drugs Market Status and Outlook
1.2 Global Diabetes Care Devices & Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Diabetes Care Devices & Drugs Market Size by Region (2018-2029)
1.4 Global Diabetes Care Devices & Drugs Historic Market Size by Region (2018-2023)
1.5 Global Diabetes Care Devices & Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Diabetes Care Devices & Drugs Market Size (2018-2029)
1.6.1 North America Diabetes Care Devices & Drugs Market Size (2018-2029)
1.6.2 Europe Diabetes Care Devices & Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Diabetes Care Devices & Drugs Market Size (2018-2029)
1.6.4 Latin America Diabetes Care Devices & Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Diabetes Care Devices & Drugs Market Size (2018-2029)
2 Diabetes Care Devices & Drugs Market by Type
2.1 Introduction
2.1.1 Insulin
2.1.2 Rapid Acting Insulin
2.1.3 Short Acting Insulin
2.1.4 Diabetes Care Devices
2.1.5 Diabetes Monitoring Devices
2.1.6 Other
2.2 Global Diabetes Care Devices & Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Diabetes Care Devices & Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Diabetes Care Devices & Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Diabetes Care Devices & Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Diabetes Care Devices & Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Diabetes Care Devices & Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Diabetes Care Devices & Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Diabetes Care Devices & Drugs Revenue Breakdown by Type (2018-2029)
3 Diabetes Care Devices & Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Household
3.2 Global Diabetes Care Devices & Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Diabetes Care Devices & Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Diabetes Care Devices & Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Diabetes Care Devices & Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Diabetes Care Devices & Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Diabetes Care Devices & Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Diabetes Care Devices & Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Diabetes Care Devices & Drugs Revenue Breakdown by Application (2018-2029)
4 Diabetes Care Devices & Drugs Competition Analysis by Players
4.1 Global Diabetes Care Devices & Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Diabetes Care Devices & Drugs as of 2022)
4.3 Date of Key Players Enter into Diabetes Care Devices & Drugs Market
4.4 Global Top Players Diabetes Care Devices & Drugs Headquarters and Area Served
4.5 Key Players Diabetes Care Devices & Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Diabetes Care Devices & Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Abbott Laboratories
5.1.1 Abbott Laboratories Profile
5.1.2 Abbott Laboratories Main Business
5.1.3 Abbott Laboratories Diabetes Care Devices & Drugs Products, Services and Solutions
5.1.4 Abbott Laboratories Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 Abbott Laboratories Recent Developments
5.2 Ascensia Diabetes Care Holdings
5.2.1 Ascensia Diabetes Care Holdings Profile
5.2.2 Ascensia Diabetes Care Holdings Main Business
5.2.3 Ascensia Diabetes Care Holdings Diabetes Care Devices & Drugs Products, Services and Solutions
5.2.4 Ascensia Diabetes Care Holdings Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Ascensia Diabetes Care Holdings Recent Developments
5.3 AstraZeneca
5.3.1 AstraZeneca Profile
5.3.2 AstraZeneca Main Business
5.3.3 AstraZeneca Diabetes Care Devices & Drugs Products, Services and Solutions
5.3.4 AstraZeneca Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Boehringer Ingelheim GmbH Recent Developments
5.4 Boehringer Ingelheim GmbH
5.4.1 Boehringer Ingelheim GmbH Profile
5.4.2 Boehringer Ingelheim GmbH Main Business
5.4.3 Boehringer Ingelheim GmbH Diabetes Care Devices & Drugs Products, Services and Solutions
5.4.4 Boehringer Ingelheim GmbH Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Boehringer Ingelheim GmbH Recent Developments
5.5 Eli Lilly And
5.5.1 Eli Lilly And Profile
5.5.2 Eli Lilly And Main Business
5.5.3 Eli Lilly And Diabetes Care Devices & Drugs Products, Services and Solutions
5.5.4 Eli Lilly And Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Eli Lilly And Recent Developments
5.6 Hoffmann-La Roche
5.6.1 Hoffmann-La Roche Profile
5.6.2 Hoffmann-La Roche Main Business
5.6.3 Hoffmann-La Roche Diabetes Care Devices & Drugs Products, Services and Solutions
5.6.4 Hoffmann-La Roche Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 Hoffmann-La Roche Recent Developments
5.7 Johnson & Johnson
5.7.1 Johnson & Johnson Profile
5.7.2 Johnson & Johnson Main Business
5.7.3 Johnson & Johnson Diabetes Care Devices & Drugs Products, Services and Solutions
5.7.4 Johnson & Johnson Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Johnson & Johnson Recent Developments
5.8 Medtronic PLC
5.8.1 Medtronic PLC Profile
5.8.2 Medtronic PLC Main Business
5.8.3 Medtronic PLC Diabetes Care Devices & Drugs Products, Services and Solutions
5.8.4 Medtronic PLC Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Medtronic PLC Recent Developments
5.9 Novartis
5.9.1 Novartis Profile
5.9.2 Novartis Main Business
5.9.3 Novartis Diabetes Care Devices & Drugs Products, Services and Solutions
5.9.4 Novartis Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Novartis Recent Developments
5.10 Novo Nordisk A/S
5.10.1 Novo Nordisk A/S Profile
5.10.2 Novo Nordisk A/S Main Business
5.10.3 Novo Nordisk A/S Diabetes Care Devices & Drugs Products, Services and Solutions
5.10.4 Novo Nordisk A/S Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Novo Nordisk A/S Recent Developments
5.11 Ypsomed
5.11.1 Ypsomed Profile
5.11.2 Ypsomed Main Business
5.11.3 Ypsomed Diabetes Care Devices & Drugs Products, Services and Solutions
5.11.4 Ypsomed Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Ypsomed Recent Developments
5.12 Terumo
5.12.1 Terumo Profile
5.12.2 Terumo Main Business
5.12.3 Terumo Diabetes Care Devices & Drugs Products, Services and Solutions
5.12.4 Terumo Diabetes Care Devices & Drugs Revenue (US$ Million) & (2018-2023)
5.12.5 Terumo Recent Developments
6 North America
6.1 North America Diabetes Care Devices & Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Diabetes Care Devices & Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Care Devices & Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Diabetes Care Devices & Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Care Devices & Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Diabetes Care Devices & Drugs Market Dynamics
11.1 Diabetes Care Devices & Drugs Industry Trends
11.2 Diabetes Care Devices & Drugs Market Drivers
11.3 Diabetes Care Devices & Drugs Market Challenges
11.4 Diabetes Care Devices & Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
